Tags

Type your tag names separated by a space and hit enter

[Epicutaneous testing with a standard series. Results in 12,026 patients].
Hautarzt. 1988 Dec; 39(12):779-86.H

Abstract

From 1977 to 1983, 12,026 patients were given patch tests with a standard series of substances. A total of 4,494 (37.4%) had positive patch-test reactions to one or more allergens; the average number of positive reactions was 1.85. The most frequent reactions were due to nickel sulphate (positive reactions in 9.2% of those tested), fragrance mix (8.9%), balsam of Peru (6.3%), cobalt chloride (4.7%), potassium dichromate (4.3%) and wool alcohols (4.3%). Women showed significantly more positive reactions than men to nickel sulphate, cobalt chloride, wool alcohols, and parabens and significantly fewer positive reactions than men to potassium dichromate, PPD mix, and epoxy resin. Younger patients showed significant more positive reactions to nickel sulphate and cobalt chloride; middle-aged patients reacted more to potassium dichromate, paraphenylendiamine, formaldehyde and thiuram mix; elderly patients reacted to balsam of Peru, wool alcohols, caine mix, neomycin sulfate, benzocaine, colophony, clioquinol, mafenide, parabens, and gentamycin sulfate.

Authors+Show Affiliations

Enders F
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München.
Przybilla B
No affiliation info available
Ring J
No affiliation info available
Burg G
No affiliation info available
Braun-Falco O
No affiliation info available

MeSH

AdultAge FactorsAllergensDermatitis, AtopicDermatitis, ContactDermatitis, OccupationalFemaleHand DermatosesHumansLeg DermatosesMaleMiddle AgedPatch TestsSex FactorsSkin Tests

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

2976753

Citation

Enders, F, et al. "[Epicutaneous Testing With a Standard Series. Results in 12,026 Patients]." Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete, vol. 39, no. 12, 1988, pp. 779-86.
Enders F, Przybilla B, Ring J, et al. [Epicutaneous testing with a standard series. Results in 12,026 patients]. Hautarzt. 1988;39(12):779-86.
Enders, F., Przybilla, B., Ring, J., Burg, G., & Braun-Falco, O. (1988). [Epicutaneous testing with a standard series. Results in 12,026 patients]. Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete, 39(12), 779-86.
Enders F, et al. [Epicutaneous Testing With a Standard Series. Results in 12,026 Patients]. Hautarzt. 1988;39(12):779-86. PubMed PMID: 2976753.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Epicutaneous testing with a standard series. Results in 12,026 patients]. AU - Enders,F, AU - Przybilla,B, AU - Ring,J, AU - Burg,G, AU - Braun-Falco,O, PY - 1988/12/1/pubmed PY - 1988/12/1/medline PY - 1988/12/1/entrez SP - 779 EP - 86 JF - Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete JO - Hautarzt VL - 39 IS - 12 N2 - From 1977 to 1983, 12,026 patients were given patch tests with a standard series of substances. A total of 4,494 (37.4%) had positive patch-test reactions to one or more allergens; the average number of positive reactions was 1.85. The most frequent reactions were due to nickel sulphate (positive reactions in 9.2% of those tested), fragrance mix (8.9%), balsam of Peru (6.3%), cobalt chloride (4.7%), potassium dichromate (4.3%) and wool alcohols (4.3%). Women showed significantly more positive reactions than men to nickel sulphate, cobalt chloride, wool alcohols, and parabens and significantly fewer positive reactions than men to potassium dichromate, PPD mix, and epoxy resin. Younger patients showed significant more positive reactions to nickel sulphate and cobalt chloride; middle-aged patients reacted more to potassium dichromate, paraphenylendiamine, formaldehyde and thiuram mix; elderly patients reacted to balsam of Peru, wool alcohols, caine mix, neomycin sulfate, benzocaine, colophony, clioquinol, mafenide, parabens, and gentamycin sulfate. SN - 0017-8470 UR - https://www.unboundmedicine.com/medline/citation/2976753/[Epicutaneous_testing_with_a_standard_series__Results_in_12026_patients]_ DB - PRIME DP - Unbound Medicine ER -